Oikos

Oikos is a Montevideo-based VC backing software startups with regional Latin American ambitions, writing seed checks under $250K. The firm is small, locally embedded, and concentrated on Uruguayan technical founders building digital health and health IT software products that can scale across Spanish-speaking Latin America. Uruguay punches above its weight as a software exporter relative to its population, with deep talent emerging from Universidad de la Republica and ORT, and Oikos positions itself as a foundational early partner for that ecosystem. The fund is not positioned as an AI-native specialist; the lens is fundamentally commercial and software-focused. The geographic focus is Uruguay with regional Latin American expansion as the natural growth path. The right founder profile is a Uruguayan technical founder building B2B software for healthcare or health IT buyers, with a working product, early commercial signal, and a credible regional expansion thesis into Argentina, Brazil, Mexico, and Chile. The wrong fit is a research-stage biotech, a US-first SaaS company, or a deep-tech AI platform; Oikos’s check size and operating focus are concentrated on commercial software at the very early stage. The right entry path is through Montevideo founder networks, through Universidad de la Republica and ORT alumni communities, through Uruguayan diaspora operators based in Buenos Aires and Sao Paulo, and through warm introductions from regional co-investors at firms like Globant Ventures, NXTP, and Magma Partners. When pitching, lead with the technical credibility, the early commercial signal, and the regional expansion logic, then connect to the unit economics that work in the Uruguayan and broader Latin American cost structure. Caveats: Oikos is a very small fund with limited follow-on capacity, and Uruguay’s domestic market alone is too small to support a venture-scale outcome, so a credible regional expansion thesis is essential. Founders should plan for the next round of capital from larger Latin American and US firms as the metrics warrant. Use Oikos as the local launchpad that anchors your Uruguayan healthtech company in its technical ecosystem and creates inbound from regional Series A investors.